294 filings
8-K
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
8-K
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
8-K
GILD
Gilead Sciences, Inc.
14 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
GILD
Gilead Sciences, Inc.
12 Feb 24
Entry into a Material Definitive Agreement
8:37am
8-K
GILD
Gilead Sciences, Inc.
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
tr85r anaq
2 Feb 24
Ted Love, MD, Joins Gilead Sciences’ Board of Directors
4:20pm
8-K
h61a7vg2 2sx3sv
7 Nov 23
Gilead Sciences Announces Third Quarter 2023 Financial Results
4:03pm
8-K
01spn5yqi k3z19jt
14 Sep 23
Entry into a Material Definitive Agreement
9:00am
8-K
ou3a70sv
16 Aug 23
Regulation FD Disclosure
5:19pm
8-K
l67b1la8dlcbn2xj
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
8-K
tdr0vqdvja4c
5 May 23
Departure of Directors or Certain Officers
11:15am
8-K
2ilbqd4q3p
27 Apr 23
Gilead Sciences Announces First Quarter 2023 Financial Results
4:05pm
8-K
erk w4oixb8
6 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
vv3 3bk55
2 Feb 23
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
4:03pm
8-K
zvoyz3y
27 Oct 22
Gilead Sciences Announces Third Quarter 2022 Financial Results
4:04pm
8-K
pmr922waab
12 Sep 22
Regulation FD Disclosure
8:00am
8-K
8r8xxazhuesm t0p9
2 Aug 22
Gilead Sciences Announces Second Quarter 2022 Financial Results
4:05pm
8-K
cwst0
28 Jul 22
Departure of Directors or Certain Officers
4:01pm
8-K
67f7j0u
31 May 22
Departure of Directors or Certain Officers
4:01pm
8-K
vbwyxi2nucd mbas
5 May 22
Submission of Matters to a Vote of Security Holders
4:01pm